Karyopharm Therapeutics Inc. · NASDAQ:KPTI
Opaleye Management Inc. reported a 9.48% stake in Karyopharm Therapeutics Inc. (Schedule 13G)
Event Oct 10, 2025 · Filed Oct 17, 2025
Opaleye Management Inc. reported a 9.48% stake in Karyopharm Therapeutics Inc., 1,569,002 shares, as a passive investor on Oct 10, 2025. Filed Oct 17, 2025 (Schedule 13G).
- Stake
- 9.48%
- Shares
- 1,569,002
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Opaleye Management Inc. | 9.48% | 1,569,002 |
| Opaleye, L.P. | 9.48% | 1,569,002 |
| James Silverman | 9.48% | 1,569,002 |
Source
Related
- Karyopharm Therapeutics Inc.
- Opaleye Management Inc.
- Karyopharm Therapeutics Inc. shareholders
- Schedule 13G/A · Opaleye Management Inc. · May 11, 2026
- Form 4 · Abate Kristin · Oct 19, 2026
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026